Author: Hadadi, Azar; Mortezazadeh, Masoud; Kolahdouzan, Kasra; Alavian, Golbarg
Title: Does recombinant human erythropoietin administration in critically ill COVIDâ€19 patients have miraculous therapeutic effects? Cord-id: 967rxomd Document date: 2020_4_19
ID: 967rxomd
Snippet: An 80â€yearâ€old man with multiple comorbidities presented to the emergency department with tachypnea, tachycardia, fever, and critically low O(2) saturation and definitive chest computerized tomography scan findings in favor of COVIDâ€19 and positive PCR results in 48 hours. He received antiviral treatment plus recombinant human erythropoietin (rhEPO) due to his severe anemia. After 7 days of treatment, he was discharged with miraculous improvement in his symptoms and hemoglobin level. We co
Document: An 80â€yearâ€old man with multiple comorbidities presented to the emergency department with tachypnea, tachycardia, fever, and critically low O(2) saturation and definitive chest computerized tomography scan findings in favor of COVIDâ€19 and positive PCR results in 48 hours. He received antiviral treatment plus recombinant human erythropoietin (rhEPO) due to his severe anemia. After 7 days of treatment, he was discharged with miraculous improvement in his symptoms and hemoglobin level. We concluded that rhEPO could attenuate respiratory distress syndrome and confront the severe acute respiratory syndrome coronavirus 2 virus through multiple mechanisms including cytokine modulation, antiapoptotic effects, leukocyte release from bone marrow, and iron redistribution away from the intracellular virus.
Search related documents:
Co phrase search for related documents- acute ards respiratory distress syndrome and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37
- admission week and lymphocyte count: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date